首页> 美国卫生研究院文献>Molecular and Cellular Biology >Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases.
【2h】

Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases.

机译:四个交替剪接的DRADA2双链RNA腺苷脱氨酶对谷氨酸受体B亚单位离子通道RNA的编辑。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Double-stranded (ds) RNA-specific adenosine deaminase converts adenosine residues into inosines in dsRNA and edits transcripts of certain cellular and viral genes such as glutamate receptor (GluR) subunits and hepatitis delta antigen. The first member of this type of deaminase, DRADA1, has been recently cloned based on the amino acid sequence information derived from biochemically purified proteins. Our search for DRADA1-like genes through expressed sequence tag databases led to the cloning of the second member of this class of enzyme, DRADA2, which has a high degree of sequence homology to DRADA1 yet exhibits a distinctive RNA editing site selectivity. There are four differentially spliced isoforms of human DRADA2. These different isoforms of recombinant DRADA2 proteins, including one which is a human homolog of the recently reported rat RED1, were analyzed in vitro for their GluR B subunit (GluR-B) RNA editing site selectivity. As originally reported for rat RED1, the DRADA2a and -2b isoforms edit GluR-B RNA efficiently at the so-called Q/R site, whereas DRADA1 barely edits this site. In contrast, the R/G site of GluR-B RNA was edited efficiently by the DRADA2a and -2b isoforms as well as DRADA1. Isoforms DRADA2c and -2d, which have a distinctive truncated shorter C-terminal structure, displayed weak adenosine-to-inosine conversion activity but no editing activity tested at three known sites of GluR-B RNA. The possible role of these DRADA2c and -2d isoforms in the regulatory mechanism of RNA editing is discussed.
机译:双链(ds)RNA特异性腺苷脱氨酶将dsRNA中的腺苷残基转化为肌苷,并编辑某些细胞和病毒基因的转录本,例如谷氨酸受体(GluR)亚基和肝炎三角洲抗原。最近已根据衍生自生物化学纯化蛋白的氨基酸序列信息克隆了这种脱氨酶的第一个成员DRADA1。我们通过表达的序列标签数据库搜索类似DRADA1的基因,导致该类酶的第二个成员DRADA2的克隆,DRADA2与DRADA1具有高度的序列同源性,但具有独特的RNA编辑位点选择性。人DRADA2有四种差异剪接的同工型。在体外分析了重组DRADA2蛋白的这些不同同工型,包括一种是最近报道的大鼠RED1的人类同源物,其GluR B亚基(GluR-B)RNA编辑位点的选择性。如最初对大鼠RED1的报道,DRADA2a和-2b亚型在所谓的Q / R位点有效编辑GluR-B RNA,而DRADA1几乎不编辑此位点。相反,GluR-B RNA的R / G位点被DRADA2a和-2b亚型以及DRADA1有效地编辑。具有独特的截短的C末端结构的同工型DRADA2c和-2d显示出较弱的腺苷到肌苷转化活性,但在三个已知的GluR-B RNA位点未测试编辑活性。讨论了这些DRADA2c和-2d同工型在RNA编辑调控机制中的可能作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号